Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Despite their benefits, access to GLP-1 medications remains inequitable
Injectable Wegovy (2.4 mg weekly) In the STEP 1 clinical trial, people taking injectable Wegovy lost an average of about 14.9% of their body weight over 68 weeks , combined with lifestyle changes
p = 0.065
For example, according to a study of over 41,000 adults with obesity, people taking tirzepatide: Were nearly twice as likely to lose at least 5% of their body weight than those taking semaglutide Were more than twice as likely to lose at least 10% of their body weight, and more than three times as likely to lose at least 15% of their body weight
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
